Are obliterative pulmonary vascular lesions reversible?

American Journal of Respiratory and Critical Care Medicine

Volumn 184, Issue 4, 2011, Pages 397-398

  West, James ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGENITAL HEART DISEASE; EDITORIAL; HUMAN; HYPOXIA; LUNG VASCULAR RESISTANCE; LUNG VENTILATION PERFUSION RATIO; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; PULMONARY VASCULAR LESION; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SHEAR STRESS; STACHYBOTRYS; VASCULAR LESION;

ANIMALS; ANTHELMINTICS; BLOOD VESSELS; FEMALE; HYPERTENSION, PULMONARY; LUNG; PRAZIQUANTEL; SCHISTOSOMIASIS MANSONI;

EID: 80051808388     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201106-1095ED     Document Type: Editorial

References (18)

1. Dammann J.F. Jr,Mc E.J., Thompson W.M. Jr, Smith R., Muller W.H. Jr. The regression of pulmonary vascular Disease after the creation of pulmonary stenosis. J Thorac Cardiovasc Surg 1961;42:722-734.
2. Wagenvoort C.A. Morphological substrate for the reversibility and irreversibility of pulmonary hypertension. Eur Heart J 1988;9:7-12.
3. Ferguson D.J., Berkas E.M., Varco R.L. Process of healing in experimental pulmonary arteriosclerosis. Proc Soc Exp Biol Med 1955;89:492-494.
4. Heath D., Helmholz H.F. Jr, Burchell H.B., Dushane J.W., Kirklin J.W., Edwards J.E. Relation between structural change in the small pulmonary arteries and the immediate reversibility of pulmonary hypertension following closure of ventricular and atrial septal defects. Circulation 1958;18:1167-1174.
5. Blank R.H., Muller W.H. Jr, Dammann J.F. Jr. Changes in pulmonary vascular lesions after restoring normal pulmonary artery pressure. Surg Forum 1958;9:356-359.
6. Geer J.C., Glass B.A., Albert H.M. The morphogenesis and reversibility of experimental hyperkinetic pulmonary vascular lesions in the dog. Exp Mol Pathol 1965;26:399-415.
7. Huang J.B., Liu Y.L., Yu C.T., Lv X.D., Du M., Wang Q., Kong B. Lung biopsy findings in previously inoperable patients with severe pulmonary hypertension associated with congenital heart disease. Int J Cardiol (In press)
8. Kent B.D., Mitchell P.D., McNicholas W.T. Hypoxemia in patients with COPD: Cause, effects, and disease progression. Int J Chron Obstruct Pulmon Dis 2011;6:199-208.
9. Naeije R., Barbera J.A. Pulmonary hypertension associated with COPD. Crit Care 2001;5:286-289. (Pubitemid 34130319)
10. Savale L., Tu L., Rideau D., Izziki M., Maitre B., Adnot S., Eddahibi S. Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice. Respir Res 2009;10:6.
11. Voelkel N.F., Tuder R.M., Wade K., Hoper M., Lepley R.A., Goulet J.L., Koller B.H., Fitzpatrick F. Inhibition of 5-lipoxygenase-activating protein (flap) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats. J Clin Invest 1996;97:2491-2498.
12. Morecroft I., Doyle B., Nilsen M., Kolch W., Mair K., Maclean M. Mice lacking the raf-1 kinase inhibitor protein exhibit exaggerated hypoxia-induced pulmonary hypertension. Br J Pharmacol 2011;163: 948-963.
13. Steiner M.K., Syrkina O.L., Kolliputi N.,Mark E.J., Hales C.A., Waxman A.B. Interleukin-6 overexpression induces pulmonary hypertension. Circ Res 2009;104:236-244.
14. Said S.I., Hamidi S.A., Dickman K.G., Szema A.M., Lyubsky S., Lin R.Z., Jiang Y.P., Chen J.J., Waschek J.A., Kort S. Moderate pulmonary arterial hypertension in male mice lacking the vasoactive intestinal peptide gene. Circulation 2007;115:1260-1268. (Pubitemid 46594770)
15. Nagayoshi M., Tada Y., West J., Ochiai E., Watanabe A., Toyotome T., Tanabe N., Takiguchi Y., Shigeta A., Yasuda T., et al. Inhalation of stachybotrys chartarum evokes pulmonary arterial remodeling in mice, attenuated by rho-kinase inhibitor. Mycopathologia (In press)
16. Crosby A., Jones F.M., Kolosionek E., Southwood M., Purvis I., Soon E., Butrous G., Dunne D.W., Morrell N.W. Praziquantel reverses pulmonary hypertension and vascular remodeling in murine schistosomiasis. Am J Respir Crit Care Med 2011;184:467-473.
17. Bethlem E.P., Schettino Gde P., Carvalho C.R. Pulmonary schistosomiasis. Curr Opin Pulm Med 1997;3:361-365. (Pubitemid 127498382)
18. Crosby A., Jones F.M., SouthwoodM., Stewart S., Schermuly R., Butrous G., Dunne D.W., Morrell N.W. Pulmonary vascular remodeling correlates with lung eggs and cytokines in murine schistosomiasis. Am J Respir Crit Care Med 2010;181:279-288.